Physician

Anthony Vu Huynh, MD

According to 2025 Medicare claims, Anthony Huynh, MD (NPI: 1497766364) practices dermatology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is ANTHONY HUYNH MEDICAL GROUP,INC (NPI: 1285746552; TIN: 710984728) and primary practice location at 92243-1313.

Huynh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,758 traditional Medicare patients, billed 24,025 HCPCS/CPT codes, and received $858,957 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,523 prescription claims across 907 beneficiaries totaling $479,013 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 82 records totaling $2,971. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $515,648 to $858,957. Similarly, Part D prescription costs have moved sharply higher in recent years, from $247,114 to $479,013. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$429K$859K2015 Medicare payment: $515,648 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $605,324 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $612,913 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $602,226 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $644,703 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $560,511 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $697,345 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $787,485 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $708,160 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $858,957 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,65312,555$515,648
20161,73617,944$605,324
20171,70826,432$612,913
20181,63327,696$602,226
20191,82628,733$644,703
20201,50622,746$560,511
20211,47024,981$697,345
20221,70728,512$787,485
20231,70324,541$708,160
20241,75824,025$858,957

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$240K$479K2015 Drug cost: $247,114 (USD; Tot_Drug_Cst)2016 Drug cost: $173,278 (USD; Tot_Drug_Cst)2017 Drug cost: $93,268 (USD; Tot_Drug_Cst)2018 Drug cost: $69,858 (USD; Tot_Drug_Cst)2019 Drug cost: $148,481 (USD; Tot_Drug_Cst)2020 Drug cost: $219,383 (USD; Tot_Drug_Cst)2021 Drug cost: $214,702 (USD; Tot_Drug_Cst)2022 Drug cost: $433,781 (USD; Tot_Drug_Cst)2023 Drug cost: $401,327 (USD; Tot_Drug_Cst)2024 Drug cost: $479,013 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157391,954$247,114
20167241,803$173,278
20175641,169$93,268
20185801,225$69,858
20195741,148$148,481
20207602,114$219,383
20217872,180$214,702
20229792,779$433,781
20238792,755$401,327
20249072,523$479,013

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths6551,489$87
11102Biopsy of related skin growth, first growth584810$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7891,318$69
17000Destruction of precancer skin growth, 1 growth5581,352$46
17003Destruction of precancer skin growth, 2-14 growths54312,996$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab25700$93,558
Dupixent PenDupilumab24672$90,702
FluocinonideFluocinonide2647,836$10,315
KetoconazoleKetoconazole46913,893$10,234
TacrolimusTacrolimus651,810$9,590

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.82$2,971Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anthony Vu Huynh, MD?

Tedicare shows public-source Medicare data for Anthony Vu Huynh, MD (NPI 1497766364), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Vu Huynh, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony Vu Huynh, MD?

Anthony Vu Huynh, MD is linked to ANTHONY HUYNH MEDICAL GROUP,INC (billing NPI 1285746552) in the available physician profile data.

Does Anthony Vu Huynh, MD have Open Payments data?

Anthony Vu Huynh, MD has 82 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.